-
1
-
-
47149112544
-
Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment
-
Blechacz B., Gores G.J. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 2008, 48:308-321.
-
(2008)
Hepatology
, vol.48
, pp. 308-321
-
-
Blechacz, B.1
Gores, G.J.2
-
4
-
-
84873308604
-
Risk factors for intrahepatic cholangiocarcinoma: Association between metformin use and reduced cancer risk
-
Hepatology,. doi:10.1002/hep.26092
-
Chaiteerakij R, Yang JD, Harmsen WS, et al. Risk factors for intrahepatic cholangiocarcinoma: Association between metformin use and reduced cancer risk. Hepatology, doi:10.1002/hep.26092.
-
-
-
Chaiteerakij, R.1
Yang, J.D.2
Harmsen, W.S.3
-
5
-
-
79959572626
-
Risk factors for cholangiocarcinoma
-
Tyson G.L., El-Serag H.B. Risk factors for cholangiocarcinoma. Hepatology 2011, 54:173-184.
-
(2011)
Hepatology
, vol.54
, pp. 173-184
-
-
Tyson, G.L.1
El-Serag, H.B.2
-
6
-
-
78650891901
-
Heterozygosity for the alpha1-antitrypsin Z allele may confer genetic risk of cholangiocarcinoma
-
Mihalache F., Hoblinger A., Grünhage F., et al. Heterozygosity for the alpha1-antitrypsin Z allele may confer genetic risk of cholangiocarcinoma. Alimentary Pharmacology and Therapeutics 2011, 33:389-394.
-
(2011)
Alimentary Pharmacology and Therapeutics
, vol.33
, pp. 389-394
-
-
Mihalache, F.1
Hoblinger, A.2
Grünhage, F.3
-
7
-
-
79959496013
-
Genetic factors in the pathogenesis of cholangiocarcinoma
-
Wadsworth C.A., Dixon P.H., Wong J.H., et al. Genetic factors in the pathogenesis of cholangiocarcinoma. Digestive Diseases 2011, 29:93-97.
-
(2011)
Digestive Diseases
, vol.29
, pp. 93-97
-
-
Wadsworth, C.A.1
Dixon, P.H.2
Wong, J.H.3
-
8
-
-
80055062562
-
Cancer surveillance in patients with primary sclerosing cholangitis
-
Razumilava N., Gores G.J., Lindor K.D. Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology 2011, 54:1842-1852.
-
(2011)
Hepatology
, vol.54
, pp. 1842-1852
-
-
Razumilava, N.1
Gores, G.J.2
Lindor, K.D.3
-
9
-
-
78651227093
-
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci
-
Melum E., Franke A., Schramm C., et al. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nature Genetics 2011, 43:17-19.
-
(2011)
Nature Genetics
, vol.43
, pp. 17-19
-
-
Melum, E.1
Franke, A.2
Schramm, C.3
-
10
-
-
48349122755
-
Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis
-
Goyette P., Lefebvre C., Ng A., et al. Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis. Mucosal Immunology 2008, 1:131-138.
-
(2008)
Mucosal Immunology
, vol.1
, pp. 131-138
-
-
Goyette, P.1
Lefebvre, C.2
Ng, A.3
-
11
-
-
0344127560
-
Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray
-
Higgins J.P., Shinghal R., Gill H., et al. Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. American Journal of Pathology 2003, 162:925-932.
-
(2003)
American Journal of Pathology
, vol.162
, pp. 925-932
-
-
Higgins, J.P.1
Shinghal, R.2
Gill, H.3
-
12
-
-
0035939903
-
Delineation of prognostic biomarkers in prostate cancer
-
Dhanasekaran S.M., Barrette T.R., Ghosh D., et al. Delineation of prognostic biomarkers in prostate cancer. Nature 2001, 412:822-826.
-
(2001)
Nature
, vol.412
, pp. 822-826
-
-
Dhanasekaran, S.M.1
Barrette, T.R.2
Ghosh, D.3
-
13
-
-
22844431612
-
P53 Mutations in human cholangiocarcinoma: a review
-
Khan S.A., Thomas H.C., Toledano M.B., et al. p53 Mutations in human cholangiocarcinoma: a review. Liver International 2005, 25:704-716.
-
(2005)
Liver International
, vol.25
, pp. 704-716
-
-
Khan, S.A.1
Thomas, H.C.2
Toledano, M.B.3
-
14
-
-
30944461587
-
Repression of the MSP/MST-1 gene contributes to the antiapoptotic gain of function of mutant p53
-
Zalcenstein A., Weisz L., Stambolsky P., et al. Repression of the MSP/MST-1 gene contributes to the antiapoptotic gain of function of mutant p53. Oncogene 2006, 25:359-369.
-
(2006)
Oncogene
, vol.25
, pp. 359-369
-
-
Zalcenstein, A.1
Weisz, L.2
Stambolsky, P.3
-
15
-
-
84868708514
-
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
-
Khan S.A., Davidson B.R., Goldin R.D., et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut 2012, 61:1657-1669.
-
(2012)
Gut
, vol.61
, pp. 1657-1669
-
-
Khan, S.A.1
Davidson, B.R.2
Goldin, R.D.3
-
16
-
-
67649205149
-
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
-
Beuers U., Boberg K.M., Chapman R.W., et al. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. Journal of Hepatology 2009, 51:237-267.
-
(2009)
Journal of Hepatology
, vol.51
, pp. 237-267
-
-
Beuers, U.1
Boberg, K.M.2
Chapman, R.W.3
-
17
-
-
72549091280
-
Attributing Hardy-Weinberg disequilibrium to population stratification and genetic association in case-control studies
-
Grover V.K., Cole D.E., Hamilton D.C. Attributing Hardy-Weinberg disequilibrium to population stratification and genetic association in case-control studies. Annals of Human Genetics 2010, 74:77-87.
-
(2010)
Annals of Human Genetics
, vol.74
, pp. 77-87
-
-
Grover, V.K.1
Cole, D.E.2
Hamilton, D.C.3
-
18
-
-
0037379406
-
Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays
-
Iacobuzio-Donahue C.A., Maitra A., Olsen M., et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. American Journal of Pathology 2003, 162:1151-1162.
-
(2003)
American Journal of Pathology
, vol.162
, pp. 1151-1162
-
-
Iacobuzio-Donahue, C.A.1
Maitra, A.2
Olsen, M.3
-
20
-
-
84861694008
-
Macrophage-stimulating protein polymorphism rs3197999 is associated with a gain of function: implications for inflammatory bowel disease
-
Häuser F., Deyle C., Berard D., et al. Macrophage-stimulating protein polymorphism rs3197999 is associated with a gain of function: implications for inflammatory bowel disease. Genes & Immunity 2012, 13:321-327.
-
(2012)
Genes & Immunity
, vol.13
, pp. 321-327
-
-
Häuser, F.1
Deyle, C.2
Berard, D.3
-
21
-
-
78651294044
-
The macrophage stimulating protein/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression
-
Kretschmann K.L., Eyob H., Buys S.S., et al. The macrophage stimulating protein/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression. Current Drug Targets 2010, 11:1157-1168.
-
(2010)
Current Drug Targets
, vol.11
, pp. 1157-1168
-
-
Kretschmann, K.L.1
Eyob, H.2
Buys, S.S.3
|